Imperva Inc (IMPV) PT Raised to $55.00 at Monness Crespi & Hardt
Imperva Inc (NYSE:IMPV) had its price target upped by Monness Crespi & Hardt from $52.00 to $55.00 in a report published on Friday, May 5th. The brokerage currently has a buy rating on the software maker’s stock.
IMPV has been the subject of a number of other research reports. Zacks Investment Research lowered Imperva from a hold rating to a sell rating in a research note on Monday, February 13th. BTIG Research assumed coverage on Imperva in a research note on Thursday, February 9th. They set a neutral rating for the company. Royal Bank of Canada restated an outperform rating and set a $52.00 price objective (up previously from $45.00) on shares of Imperva in a research note on Thursday, February 9th. Evercore ISI restated a buy rating and set a $56.00 price objective on shares of Imperva in a research note on Friday, May 5th. Finally, DA Davidson restated a buy rating and set a $55.00 price objective on shares of Imperva in a research note on Wednesday, March 22nd. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have assigned a buy rating to the stock. The stock has a consensus rating of Hold and a consensus price target of $48.42.
Imperva (NYSE:IMPV) traded down 0.52% on Friday, reaching $47.40. 88,076 shares of the company’s stock were exchanged. The firm’s market cap is $1.59 billion. Imperva has a one year low of $34.25 and a one year high of $57.24. The firm has a 50 day moving average price of $44.03 and a 200 day moving average price of $41.24.
Imperva (NYSE:IMPV) last released its earnings results on Thursday, May 4th. The software maker reported ($0.29) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.62) by $0.33. Imperva had a negative return on equity of 28.37% and a negative net margin of 25.60%. The firm had revenue of $72.31 million for the quarter, compared to the consensus estimate of $68.16 million. During the same period in the prior year, the business posted ($0.25) earnings per share. The firm’s revenue for the quarter was up 21.0% compared to the same quarter last year. On average, equities analysts anticipate that Imperva will post $0.45 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This piece was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/05/19/imperva-inc-impv-pt-raised-to-55-00-at-monness-crespi-hardt-updated.html.
In other Imperva news, CFO Terrence J. Schmid sold 4,500 shares of the business’s stock in a transaction on Tuesday, February 21st. The shares were sold at an average price of $45.53, for a total transaction of $204,885.00. Following the sale, the chief financial officer now owns 432 shares of the company’s stock, valued at $19,668.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Sunil D. Nagdev sold 4,857 shares of the business’s stock in a transaction on Tuesday, May 16th. The stock was sold at an average price of $49.00, for a total transaction of $237,993.00. Following the sale, the senior vice president now directly owns 16,290 shares in the company, valued at approximately $798,210. The disclosure for this sale can be found here. Insiders sold 201,149 shares of company stock worth $9,091,262 over the last three months. 2.20% of the stock is currently owned by insiders.
Several institutional investors have recently modified their holdings of the company. Ameritas Investment Partners Inc. acquired a new position in shares of Imperva during the first quarter worth approximately $102,000. KCG Holdings Inc. acquired a new position in shares of Imperva during the first quarter worth approximately $201,000. Seven Eight Capital LP acquired a new position in shares of Imperva during the fourth quarter worth approximately $207,000. US Bancorp DE raised its position in shares of Imperva by 142.3% in the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock worth $221,000 after buying an additional 3,163 shares during the period. Finally, Jane Street Group LLC acquired a new position in shares of Imperva during the first quarter worth approximately $224,000. Institutional investors own 92.72% of the company’s stock.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Stock Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related stocks with our FREE daily email newsletter.